Reduced uncertainty with innovative cardiac diagnostics

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=AzLZ9N7JO_Q

Dr Twerenbold, cardiologist, highlights how the innovation of high sensitive troponins impacts not only the health system and physicians but also how it brings value to our key stakeholder: the patient. • Developed in the early 2000s, high sensitive troponins revolutionised the diagnosis of myocardial injury by providing accurate and faster results and by detecting more patients with smaller infarctions compared to conventional diagnostic approaches. • At Roche, we are passionate about urgently delivering medical solutions and developing innovations for the future. • Subscribe to our YouTube channel now: https://www.youtube.com/user/roche?su... • Get in touch with us: • https://www.roche.com/ • / roche • / roche • / roche • / roche • Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. • Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. • For more information and insights visit: https://www.roche.com/

#############################

New on site